OPTX

Business Context and Reporting Period

Company: Syntec Optics Holdings, Inc. (OPTX)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and six months ended June 30, 2025
Business Overview: A vertically integrated manufacturer of optics and photonics components serving defense, medical, consumer, and communication end-markets. The company operates as a single reporting segment from its facility in Rochester, New York.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue: Net sales decreased 6.4% year-over-year for the quarter ($6.6M vs. $7.0M) due to a $1.0M decline in the consumer market, partially offset by growth in communications and defense. For the six-month period, sales increased 2.8% ($13.6M vs. $13.3M), driven by defense, medical, and communications growth.
• Profitability: Gross margin for the quarter declined to 24% from 31% in the prior year due to increased material costs. However, the six-month gross margin improved to 29% from 22%, driven by volume increases and reduced manufacturing overhead.
• Net Income: The company reported a net loss of $344k for the quarter compared to a net income of $282k in the prior year. For the six months, the net loss narrowed significantly to $20k compared to a $927k loss in the prior year.
• Expenses: General and Administrative (G&A) expenses decreased 13.5% for the quarter and 14.7% for the six months, driven by reductions in professional fees, consulting, and travel.
• Other Income: Other income decreased significantly due to the absence of a one-time book gain on the sale of assets recorded in the prior year.

Guidance, Outlook, Risks, and Unusual Items

• Liquidity: As of June 30, 2025, the company held $287k in cash with $1.7M available under an $8M line of credit. The company remains in compliance with all financial covenants.
• Internal Controls: Management concluded that disclosure controls and procedures were not effective due to nine identified material weaknesses. These include lack of formal internal control processes, insufficient segregation of duties, lack of timely reconciliations, and inadequate IT general controls. Remediation plans are underway.
• Customer Concentration: Three customers accounted for 43% of revenue in the quarter and 41% for the six months ended June 30, 2025.
• Unusual Items: Adjusted EBITDA reconciliations include non-recurring items such as executive transition costs ($249k for six months) and one-time contract exit costs.
• Outlook: Management anticipates continued growth in defense, medical, and communications markets. The company plans to pursue bolt-on acquisitions for inorganic growth.

Investor Verification Checklist

• Internal Control Remediation: Verify the progress of remediation plans for the nine material weaknesses in internal controls, specifically regarding segregation of duties and IT general controls.
• Customer Concentration: Assess the stability of the top three customers representing ~40% of revenue and the risk of concentration.
• Debt Covenants: Monitor compliance with the M&T Bank credit agreement covenants (fixed charge coverage, leverage ratio, EBITDA) given the high debt load relative to cash flow.
• Margin Sustainability: Evaluate whether the improved six-month gross margin is sustainable given the volatility in material costs and the shift in product mix away from the consumer market.
• Cash Burn vs. Generation: Confirm the ability to sustain operations with current cash levels ($287k) and reliance on the line of credit, especially given the net cash outflow from investing activities ($605k).